FDA Inspection 1325206 — Robert W. Levin, M.D.
The FDA completed an inspection of Robert W. Levin, M.D. on July 1, 2026 in Clearwater, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 1, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Clearwater, FL (United States)
Additional Details
Clinical BA/BE